Brief: Sensei Biotherapeutics Says On Sept 17, Co Appointed Josiah Craver As Co’S Principal Financial Officer And Principal Accounting Officer
20/09/2024 21:34
Sept 20 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS- ON SEPT 17, CO APPOINTED JOSIAH
CRAVER
AS CO’S PRINCIPAL FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING
OFFICER
Source text for Eikon: ID:n0001193125-24-222937
Further company coverage: SNSE.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Faeth Therapeutics,
See all newsBrief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)